This analysis reflects the recommendations and expertise of an international group of leaders in blood transfusion, biomedical ethics, health policy, and law. @transfusion.health @aabbupdates.bsky.social @isbt.bsky.social

Wow I had no idea! I feel like we all look to y’all as the gold standard. Hopefully one day with AI we will be able to have the ability to access antigen genotype or at least alloantibody status irrespective of country borders

Basically I always invoke Canada as the standard the US should aspire to regarding alloantibody databases, so let me know if should pick a different example 😅

I thought Canada outside of Quebec (and Quebec itself) had an alloantibody registry? Or is this just for certain patient populations (eg sickle cell disease)? Completely agree that even with ‘low’ alloimmunization rates, the issue is knowing about them once they evanesce. Cool study!